Skip to main content
. 2017 Sep 6;7:10607. doi: 10.1038/s41598-017-10886-x

Figure 8.

Figure 8

A schematic working model for the mechanisms of cisplatin resistance mediated by O-GlcNAcylation. Depending on the cellular context, O-GlcNAcylation targets either p53 or c-Myc in cisplatin-treated cells and interferes with its ubiquitin-mediated proteasomal degradation that causes either p53 degradation or c-Myc stabilization.